Background illustration for clinical trials search

Paid Clinical Trials Princeton

Discover 1,660 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Hackensack NJ, Norfolk VA, Buffalo NY, Durham NC,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase3, Recruiting

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

for
Relapsed or Refractory Hematologic Malignancies
Location: Hackensack NJ, Washington DC, Lafayette IN, Fairway KS,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03838926

Phase1, Recruiting

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

for
Focal Onset Seizure, Primary Generalized Epilepsy
Location: Hackensack NJ, Middletown NY, Bethesda MD,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 18 - 70+

Code: NCT06908356

Phase2, Recruiting

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

for
Non-small Cell Lung Cancer
Location: Hackensack NJ, Stamford CT, Lancaster PA, Farmington CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07190248

Phase3, Recruiting

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

for
Allogeneic Stem Cell Transplant Recipient
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18 - 65

Code: NCT07214688

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

for
Locally Advanced or Metastatic Malignant Solid Tumors
Location: Hackensack NJ, New Hyde Park NY, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07287995

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

for
Hepatocellular Carcinoma (HCC)
Location: Hackensack NJ, Nashville TN, Duarte CA, Portland OR
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07291076

Phase1, Phase2, Recruiting

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Hackensack NJ, Boston MA, St Louis MO, San Antonio TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07414836

Phase1, Recruiting

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

for
Advanced Malignant Tumors
Location: Hackensack NJ, Quebec, Germantown TN, Vancouver
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06764771

Phase1, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: New York NY, Clifton NJ, Wilmington NC,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase3, Recruiting

A Study of BG-C477 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Hackensack NJ, New Haven CT, Peoria IL, Jackson MS,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06596473

Phase1, Recruiting

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

for
Gastroenteropancreatic Neuroendocrine Tumor
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07635316

Recruiting

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

for
Multiple Myeloma
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18+

Code: NCT03909412

Phase1, Recruiting

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

for
Prostate Adenocarcinoma
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: Male

Age: 18+

Code: NCT06798558

Phase2, Recruiting

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for
Prostate Cancer
Location: Hackensack NJ, Atlanta GA, Portland OR
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07543055

Phase1, Recruiting

Evaluating Novel Therapies in ctDNA Positive GI Cancers

for
Colon Adenocarcinoma, Rectal Adenocarcinoma,
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT05482516

Phase3, Recruiting

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

for
Advanced Solid Tumor, Malignant Solid Tumor
Location: Hackensack NJ, Denver CO, Sarasota FL
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT04145622

Phase1, Phase2, Recruiting

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

for
Follicular Lymphoma
Location: Hackensack NJ, Durham NC, Lexington KY, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07634471

Phase2, Phase3, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Hackensack NJ, Toronto, Montreal, Vancouver,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06476808

Phase1, Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

for
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma,
Location: Hackensack NJ, Boston MA, Pittsburgh PA, Buffalo NY,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06469281

Phase1, Recruiting